Astrana Health Stock
Astrana Health, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Brandon K. Sim
- Employees
- 3,000
- Market cap
- $1.8 B
- IPO
- 11/03/2009
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California. Founded in 1985, the company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. The…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Astrana Health stock: price history
1D
-3.2%
1W
-2.0%
1M
-2.4%
6M
+16.9%
YTD
+48.4%
1Y
+15.8%
2Y
-41.1%
5Y
-48.5%
10Y
+873.8%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~33% weaker price swings than usual
Astrana Health stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Astrana Health
Analyst assessment of Astrana Health
PRICE TARGET LOW
US$41.00
CONSENSUS
US$52.00
MEDIAN
US$53.00
PRICE TARGET HIGH
US$65.00
0
STRONG BUY
11
BUY
0
HOLD
0
SELL
0
STRONG SELL
11
TOTAL · Buy
As of: 01/10/2026
Astrana Health stock metrics
P/E
44.48
P/B
2.18
EV/EBITDA
12.63
RETURN ON EQUITY
2.4%
NET MARGIN
2.0%
DEBT/EQUITY
1.18
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
79.1%
FLOAT SHARES
39,225,374
AVG. DAILY VOLUME (30D)
393,338
Insider transactions (SEC)
Vong John
Sim Brandon
Lam Thomas S.
Basho Chandan
Vong John
Dividends & Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Astrana Health stock
What does Astrana Health do?
Astrana Health, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Brandon K. Sim, the company employs around 3,000 people.
The IPO was on 11/03/2009; the stock trades on NASDAQ under the ticker ASTH.
What do analysts say about Astrana Health stock?
11 analysts rate the stock, the consensus is Buy (as of 01/10/2026).
The average price target is US$52.00, ranging from US$41.00 to US$65.00, with a median of US$53.00.
This is an external assessment, not a statement by Market Jury.
When does Astrana Health report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly -33% stronger than usual.
Does Astrana Health pay a dividend?
No, Astrana Health currently does not pay a dividend.
Which stocks are comparable to Astrana Health?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get Astrana Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess Astrana Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.